Skip to content

The effect of Etrifel (a product of Iranian traditional medicine) on patients with migraine and gastrointestinal symptoms

The effect of Etrifel (a product of Iranian traditional medicine) on patients with migraine and gastrointestinal symptoms

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180416039331N1
Enrollment
140
Registered
2018-08-24
Start date
2016-07-22
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

??????? ?????? ????? ????? ??????? ????. Other headache syndromes

Interventions

Intervention 1: Intervention group: Daily treatment with sodium valproate 200 mg per day and Attrafilet Minor 50 mg before lunch and dinner. Intervention 2: Control group: Daily treatment with sodium

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Migraine sufferers with gastrointestinal symptoms (peptic ulcer) based on the diagnostic CRIs contained in authentic traditional medicine texts. Their headache has been confirmed by a clinical examination and diagnosis of a physician according to the IHS diagnostic criteria. Patients are aware of their diagnosis. Persian and know the Persian language and are available. Number of headache attacks at least 4 times a month with a duration of more than 30 minutes and severity of 4 or more (according to VAS). Patient's written consent.

Exclusion criteria

Exclusion criteria: Patient dissatisfaction with the continuation of the study. The patient is diagnosed during or before the pregnancy. Drug and alcohol abuse, or other traditional medicine, such as needles or herbal medicines

Design outcomes

Primary

MeasureTime frame
Determine the rate of recovery from atrophil in migraine patients with gastroenterological symptoms. Timepoint: Before the intervention and 8 weeks after the intervention, the physician's global assessment was evaluated. Also, 4 weeks after the start of the intervention, a questionnaire was used to answer the treatment and possible complications. Method of measurement: Notes and daily reports of patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Emtiazy

Yazd University of Medical Sciences

tebsonati@ssu.ac.ir+98 35 3723 8915

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026